Advertisement

Tumor Biology

, Volume 36, Issue 8, pp 6587–6587 | Cite as

Erratum to: CIP2A mediates prostate cancer progression via the c-MYC signaling pathway

Erratum

Erratum to:Tumor Biol. 36 (5):3583–3589

DOI 10.1007/s13277-014-2995-5

Tumor Biol. 36(6):4777–4783

DOI 10.1007/s13277-015-3129-4

This article was unintentionally published twice in this journal, by the same authors. Following should be considered the version of record and used for citation purposes: “Zexiong Guo, Dehao Liu, Zexuan Su, CIP2A mediates prostate cancer progression via the c-MYC signaling pathway, Tumor Biology, Volume 36, Issue 6, pages 4777–4783, DOI  10.1007/s13277-015-3129-4”.

The duplicate “Zexiong Guo, Dehao Liu, Zexuan Su, CIP2A mediates prostate cancer progression via the c-MYC signaling pathway, Tumor Biology, Volume 36, Issue 5, pages 3583–3589, DOI  10.1007/s13277-014-2995-5” is to be ignored.

Torgny Stigbrand/Springer apologizes to the readers of the journal for not detecting the duplication during the publication process.

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  1. 1.Department of UrologyFirst Affiliated Hospital of Jinan UniversityGuangzhouPeople’s Republic of China

Personalised recommendations